{
    "SPADE_UN_14122": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_14122",
            "Peptide Name": "C34S[138T]",
            "Source": "Synthetic construct(derived from C34)",
            "Family": "Retroviridae",
            "Gene": "Not found",
            "Sequence": "WMEWDREINNYTSLIHSLIEETQNQQEKNEQELL",
            "Sequence Length": 34,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=2.6± 0.2 nM);HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=4.8± 1.3 nM);HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=32 ± 5.5 nM);HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=24 ±6.6nM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C185H282N50O64S",
            "Mass": 4262.58,
            "PI": 4.21,
            "Net Charge": -5,
            "Hydrophobicity": -1.27,
            "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min",
            "Mechanism of action": "The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.",
            "Literature": [
                {
                    "Title": "Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.",
                    "Pubmed ID": "19073606",
                    "Reference": "J Biol Chem. 2009 Feb 20;284(8)4914-20.",
                    "Author": "Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=19073606"
                }
            ],
            "Frequent Amino Acids": "ELN",
            "Absent Amino Acids": "ACFGOPUV",
            "Basic Residues": 3,
            "Acidic Residues": 8,
            "Hydrophobic Residues": 11,
            "Polar Residues": 16,
            "Positive Residues": 3,
            "Negative Residues": 8,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_10074",
                    "Similarity": 1.0,
                    "Sequence": "NKSLEQIWNNMTWMEWDREINNYTSLIHSLIEEQNQQEKNEQELLELDKWASLWNWF"
                },
                {
                    "SPADE_ID": "SPADE_UN_10181",
                    "Similarity": 1.0,
                    "Sequence": "NASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLI"
                },
                {
                    "SPADE_ID": "SPADE_UN_14468",
                    "Similarity": 1.0,
                    "Sequence": "EWDREINNYTSLIHSLIEEQNQQEKNEQELLELDKWASLW"
                }
            ]
        }
    }
}